1. Home
  2. FIP vs ARVN Comparison

FIP vs ARVN Comparison

Compare FIP & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FIP

FTAI Infrastructure Inc.

HOLD

Current Price

$4.49

Market Cap

683.0M

Sector

Industrials

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$9.53

Market Cap

658.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIP
ARVN
Founded
2021
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
683.0M
658.2M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
FIP
ARVN
Price
$4.49
$9.53
Analyst Decision
Strong Buy
Buy
Analyst Count
2
19
Target Price
$11.00
$15.05
AVG Volume (30 Days)
1.0M
697.6K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
2.12%
N/A
EPS Growth
16.91
58.84
EPS
N/A
N/A
Revenue
$502,520,000.00
$262,600,000.00
Revenue This Year
$58.19
N/A
Revenue Next Year
$30.58
N/A
P/E Ratio
N/A
N/A
Revenue Growth
51.59
N/A
52 Week Low
$3.90
$5.90
52 Week High
$7.93
$14.22

Technical Indicators

Market Signals
Indicator
FIP
ARVN
Relative Strength Index (RSI) 34.14 33.96
Support Level $4.33 $9.02
Resistance Level $6.34 $10.18
Average True Range (ATR) 0.42 0.64
MACD -0.13 -0.04
Stochastic Oscillator 4.56 23.11

Price Performance

Historical Comparison
FIP
ARVN

About FIP FTAI Infrastructure Inc.

FTAI Infrastructure Inc is engaged in five segments; Railroad segment, which includes eight freight railroads and one switching company that provide rail service to certain manufacturing and production facilities; the Jefferson Terminal segment, which consists of a multi-modal crude oil and refined products terminal and other related assets; The Repauno segment, which consists of a deep-water port located along the Delaware River with an underground storage cavern, a multipurpose dock, a rail-to-ship transloading system, and multiple industrial development opportunities; Power and Gas segment, which comprised Long Ridge, a multi-modal terminal located along the Ohio River; and Sustainability and Energy Transition segment, which comprised of Aleon/Gladieux, Clean Planet, and CarbonFree.

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: